Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
451.20    -11.40 (-2.46%)
Bid:
451.00
Ask:
451.80
Spread: 0.80 (0.177%)
Market Cap: £2.32b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

First Quarter Trading Update

21 Jul 2021 07:00

RNS Number : 8784F
QinetiQ Group plc
21 July 2021
 

News release

 

QinetiQ Group plc

First Quarter Trading Update

21 July 2021 - QinetiQ Group plc ("QinetiQ" or "the Group") today issues a trading update covering its first quarter of trading.

Strong first quarter performance

We have made a good start to the new financial year, with strong group operational performance. Orders, revenue, profit and cash are in-line with expectations. Our visibility on revenue under contract for FY22 has increased to £940m, up from £800m at April 2021, and we continue to mitigate the impact of COVID-19. Consequently, we remain confident of delivering in line with our expectations, with mid-single digit organic revenue growth at 11% to 12% operating profit margin, rising to 12% to 13% operating profit margin in the medium term.

We have seen a strong start to the year in EMEA Services, in particular with continued good order intake in the Cyber & Information business and strong revenue growth in the Maritime & Land business, this is partially offset by a slower quarter for Global Products due to lower year-end backlog. Overall, the Group is showing good continued growth and profitability in line with our expectations.

Strategy Update

Our strategy to build an integrated global defence and security company with revenues of more than £2bn is continuing to deliver well. Building on our successful 5-year track record of growth, we are continuing to deliver for our customers and on our promises. We remain focussed on our six home and priority countries and our six distinctive offerings, using our balance sheet to support growth into our >£20bn addressable market through both strong organic growth and strategically aligned acquisitions. In the first quarter, we achieved a number of successes that demonstrate our delivery on strategic objectives:

International successes - Through the first quarter we have seen strong progress in our international markets. In Australia we achieved a first order for SPUR robots demonstrating global leverage of our capabilities from the US into Australia, in Germany we saw strong recovery in training flying hours, in Canada we signed a framework agreement to support the Canadian navy and other forces in future maritime operations development and in Belgium we won a contract with the European Space Agency to deliver and operate a new satellite to support technological innovation, de-risking and concept testing for public agencies and commercial enterprises in Europe.

SPECTRE contract in the US - Building on the successful delivery and trials of our ISR prototype system on a Program of Record, we have won a $24m contract from the US Army to build three additional SPECTRE next generation full spectrum hyperspectral prototype sensors. SPECTRE is an ISR (intelligence, surveillance and reconnaissance) sensor system that enables multi-mission Uncrewed Aircraft Systems (UAS) and crewed aircraft to operate in parallel to other critical sensor payloads and weapons, with improved performance at a fraction of the size and weight of the sensors currently in use by the US Government. This is exciting progress for our US business, with opportunity for greater exploitation in the future.

Formidable Shield 21 - We supported Formidable Shield, the largest live-fire Integrated Air and Missile Defence exercise in 2021 led by US Sixth Fleet and conducted by Naval Striking and Support Forces NATO. In total, 16 ships, 31 aircraft, and approximately 3,300 personnel from ten NATO nations participated in the live training event at the Hebrides range. We provided the safe environment, logistics and range control to facilitate this trial, across the maritime and air domains. A range of targets were used to test defences, including subsonic, supersonic and ballistic targets. This is an excellent example of our investment in the LTPA contract driving enhanced operational outcomes for our customers, increasing the demand for our ranges and QinetiQ being at the leading edge of safe delivery of complex events to ensure our NATO allies can defend against future threats.

Strike Warrior 21 - We supported the Royal Navy Carrier Strike Group Strike Warrior exercise at MOD Aberporth and Hebrides ranges, with our operational training and missions system business Inzpire, supporting the overall training activity using its God's Eye View (GEV) capability. Exercise Strike Warrior involved more than 20 warships, three submarines and 150 aircraft from 11 nations and was the final test for the Carrier Strike Group before its first operational deployment. The GEV system developed by QinetiQ enabled the Royal Navy and Royal Air Force to enhance the training value from the exercise with a near real time picture of the overall exercise tracking each asset across waters off north-west Scotland by connecting sensors across the Hebrides range and RAF bases through a digital backbone.

BATCIS contract extension - In 2018 we won a significant competitive programme to provide Private Sector client side Support to the Battlefield Tactical Communication and Information Systems (BATCIS) Delivery Team within Defence Digital (within MOD). The contract is a critical enabler to deliver the next generation of Tactical Communication and Information Systems as part of a Single Information Environment for UK armed forces. Following the strong delivery in the first three years of the programme by both QinetiQ and in collaboration with our partners (Roke, ATOS and BMT) and suppliers, we have been awarded a one year extension.

Pension bulk annuity insurance buy-in - As reported in our 2021 Annual Report and Accounts, the Scheme completed a further bulk annuity insurance buy-in at a cost of £132m, to remove longevity risk, interest rate risk and inflation risk. This follows the buy-in in 2019, taking the de-risked element to over £800m (or more than 40% of the Scheme's £1.86bn present value liabilities, as at 31 March 2021).

 

On 2 July 2021, we announced that David Smith, Chief Financial Officer, intended to retire and that he would be succeeded by Carol Borg from 1 December 2021. Carol will commence her employment with QinetiQ and join the Board on 11 October 2021 to enable a smooth transition period prior to David's departure.

AGM

QinetiQ's 2021 Annual General Meeting (AGM) will be held at 10am today at Cody Technology Park, Ively Road, Farnborough, GU14 0LX.

About QinetiQ

QinetiQ (QQ.L) is a leading science and engineering company operating primarily in the defence and security markets. We work in partnership with our customers to solve real world problems through innovative solutions delivering operational and competitive advantage. Visit our website www.QinetiQ.com. Follow us on LinkedIn and Twitter @QinetiQ. Visit our blog www.QinetiQ-blogs.com.

For further information please contact:

John Haworth, Group Head of Investor Relations:

+44 (0) 7920 545841

Chris Barrie, Citigate Dewe Rogerson (Media enquiries):

+44 (0) 7968 727289

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTZBLFLFDLZBBZ
Date   Source Headline
16th Nov 202111:24 amRNSDirector/PDMR Shareholding
11th Nov 20217:00 amRNSInterim Results
10th Nov 202112:12 pmRNSDirector/PDMR Shareholding
1st Nov 202111:43 amRNSBlock listing Interim Review
19th Oct 20219:16 amRNSHolding(s) in Company
14th Oct 20217:00 amRNSTrading Update
12th Oct 202110:43 amRNSDirector/PDMR Shareholding
10th Sep 20212:07 pmRNSDirector/PDMR Shareholding
31st Aug 20212:35 pmRNSDirector/PDMR Shareholding
11th Aug 20219:07 amRNSDirector/PDMR Shareholding
27th Jul 202110:46 amRNSDirectorate Change
26th Jul 20214:33 pmRNSDirector/PDMR Shareholding
21st Jul 202110:55 amRNSResult of AGM
21st Jul 20217:00 amRNSFirst Quarter Trading Update
14th Jul 20218:47 amRNSChange of AGM venue
13th Jul 20219:52 amRNSHolding(s) in Company
12th Jul 202111:12 amRNSDirector/PDMR Shareholding
2nd Jul 20217:00 amRNSChief Financial Officer succession
29th Jun 20213:49 pmRNSDirector/PDMR Shareholding
15th Jun 202110:55 amRNSAnnual Financial Report
10th Jun 202111:15 amRNSDirector/PDMR Shareholding
9th Jun 20215:01 pmRNSDirector/PDMR Shareholding
1st Jun 20219:34 amRNSTotal Voting Rights
25th May 202110:54 amRNSBlock Listing Application
20th May 20217:00 amRNSPreliminary Results
11th May 20211:53 pmRNSDirector/PDMR Shareholding
27th Apr 20212:08 pmRNSDeath of Non-Executive Director, Ian Mason
15th Apr 20212:49 pmRNSHolding(s) in Company
14th Apr 20217:00 amRNSTrading Update
12th Apr 20212:00 pmRNSDirector/PDMR Shareholding
12th Apr 20218:32 amRNSHolding(s) in Company
10th Mar 202112:23 pmRNSDirector/PDMR Shareholding
4th Mar 20217:00 amRNSInvestor Seminar
16th Feb 20218:55 amRNSDirector Declaration
10th Feb 202111:32 amRNSDirector/PDMR Shareholding
8th Feb 20219:57 amRNSDirector/PDMR Shareholding
13th Jan 20217:00 amRNSThird Quarter Trading Update
12th Jan 20219:49 amRNSDirector/PDMR Shareholding
4th Jan 20217:00 amRNSQinetiQ wins £127m Typhoon contract through EDP
21st Dec 20204:44 pmRNSHolding(s) in Company
10th Dec 202010:28 amRNSDirector/PDMR Shareholding
3rd Dec 20201:00 pmRNSSale of OptaSense to Luna
24th Nov 20201:31 pmRNSDirector/PDMR Shareholding
20th Nov 202012:37 pmRNSDirector/PDMR Shareholding
20th Nov 202011:43 amRNSHolding(s) in Company
17th Nov 202011:16 amRNSDirector/PDMR Shareholding
12th Nov 20207:00 amRNSInterim Results
10th Nov 202010:47 amRNSDirector/PDMR Shareholding
12th Oct 202010:09 amRNSDirector/PDMR Shareholding
5th Oct 20209:10 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.